top of page


PNGAF Is Coming For Big Pharma’s $82 Billion GLP-1 Market
Anyone who knows someone on Ozempic or Mounjaro knows the weekly routine of taking a pen out of the refrigerator and pushing a needle into the stomach, and most other peptides still reach people the same way. The Precision Peptide Company (CSE: $BPC) (OTCQB: $PNGAF) is replacing that routine with peptide patches that stick to the skin like a bandage and deliver a measured dose without a syringe or a refrigerator. PNGAF has four of those patches in its line with the first alre

Checkers
2 hours ago5 min read
bottom of page

